Melanoma death prevention: Moving away from the sun

Journal of the American Academy of Dermatology

Volumn 68, Issue 6, 2013, Pages

  Mitchell, Jeanette Kamell ^a,b   Leslie, Kieron S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Conejo Dermatology Medical Group ^*  (United States)

Author keywords

cause marketing; cost effectiveness; melanoma; melanoma advocacy; melanoma education; melanoma outreach; risk stratification; screening guidelines; secondary prevention; self skin examination; skin cancer screening

Indexed keywords

CARCINOGEN; SUNSCREEN;

ARTICLE; AWARENESS; BREAST CANCER; BREAST EXAMINATION; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DERMATOLOGIST; DIAGNOSTIC ERROR; GENERAL PRACTITIONER; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; MASS SCREENING; MELANOMA; PATIENT EDUCATION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY PREVENTION; SKIN EXAMINATION; SUN; SUN EXPOSURE; SUNGLASSES; ULTRAVIOLET RADIATION;

EID: 84877801291     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.09.028     Document Type: Editorial

References (48)

1. N.G. Burnet, S.J. Jeffries, R.J. Benson, D.P. Hunt, and F.P. Treasure Years of life lost (YLL) from cancer is an important measure of population burden-and should be considered when allocating research funds Br J Cancer 92 2005 241 245
2. D.S. Rigel, and J.A. Carucci Malignant melanoma: prevention, early detection, and treatment in the 21st century CA Cancer J Clin 50 2000 216 236
3. NIH Consensus Conference Diagnosis and treatment of early melanoma JAMA 268 1992 1314 1319
4. S. Sahin, B. Rao, A.W. Kopf, E. Lee, D.S. Rigel, and R. Nossa Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model Cancer 80 1997 1426 1431
5. Surveillance Research Program, National Cancer Institute. Fast stats: an interactive tool for access to SEER cancer statistics. Available from: URL: http://seer.cancer.gov/faststats. Accessed June 13, 2011.
6. B.W. Hesse, L.E. Johnson, and K.L. Davis Extending the reach, effectiveness, and efficiency of communication: evidence from centers of excellence in cancer communication research Patient Educ Couns 81 Suppl 2010 S1 S5
7. US Department of Health and Human Services. Healthy people 2020 cancer objectives (C-8). Available from: URL: healthypeople.gov/2020/ topicsobjectives2020/objectiveslist.aspx?topicId=5. Accessed July 20, 2012.
8. Institute for Work and Health. Primary, secondary, and tertiary prevention. Available from: URL: http://www.iwh.on.ca/primary-secondary-and- tertiary-prevention. Accessed June 30, 2012.
9. G.B. Ivry, C.A. Ogle, and E.K. Shim Role of sun exposure in melanoma Dermatol Surg 32 2006 481 492
10. J.K. Rivers Is there more than one road to melanoma? Lancet 363 2004 728 730
11. D. Wartman, and M. Weinstock Are we overemphasizing sun avoidance in protection from melanoma? Cancer Epidemiol Biomarkers Prev 17 2008 469 470
12. US Department of Health and Human Services, Public Health Service, National Toxicology Program. Report on carcinogens. 11th ed. 2011. Available from: URL: http://ntp.niehs.nih.gov/ntp/roc/twelfth/roc12.pdf. Accessed July 19, 2012.
13. J.S. Bordeaux, K.Q. Lu, and K.D. Cooper Melanoma: prevention and early detection Semin Oncol 34 2007 460 466
14. C. Sinclair, and P. Foley Skin cancer prevention in Australia Br J Dermatol 161 2009 116 123
15. J. Bauer, P. Büttner, T.S. Wiecker, H. Luther, and C. Garbe Interventional study in 1,232 young German children to prevent the development of melan ocytic nevi failed to change sun exposure and sun protective behavior Int J Cancer 116 2005 755 761
16. N.R. Abbasi, H.M. Shaw, D.S. Rigel, R.J. Friedman, W.H. McCarthy, and I. Osman Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria JAMA 292 2004 2771 2776
17. M.A. Richard, J.J. Grob, M.F. Abril, M. Delaunay, J. Goubernet, and P. Wolkenstein Delays in diagnosis and melanoma prognosis (I): the role of patients Int J Cancer 89 2000 271 279
18. A. Blum, C. Ingvar, M. Avramidis, A. von Kannen, S.W. Menzies, and H. Olsson Time to diagnosis of melanoma: same trend in different continents J Cutan Med Surg 11 2007 137 144
19. S.M. Swetter, T.M. Johnson, D.R. Miller, C.J. Layton, K.R. Brooks, and A.C. Geller Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness Arch Dermatol 145 2009 397 404
20. K.B. Lee, M.A. Weinstock, and P.M. Risica Components of a successful intervention for monthly skin self-examination for early detection of melanoma: the "Check It Out" trial J Am Acad Dermatol 58 2008 1006 1012
21. M. Janda, R.E. Neale, P. Youl, D.C. Whiteman, L. Gordon, and P.D. Baade Impact of a video-based intervention to improve the prevalence of self-skin exam in men >50: randomized skin awareness trial Arch Dermatol 147 2011 799 806
22. C.R. Rossi, A. Vecchiato, G. Bezze, G. Mastrangelo, M.C. Montesco, and S. Mocellin Early detection of melanoma: an educational campaign in Padua, Italy Melanoma Res 10 2000 181 187
23. R.M. MacKie, and D. Hole Audit of public education campaign to encourage earlier detection of malignant melanoma BMJ 304 1992 1012 1015
24. T. Wolff, E. Tai, and T. Miller Screening for skin cancer: an update of the evidence for the US Preventative Services Task Force Ann Intern Med 150 2009 194 198
25. A.C. Geller, S.M. Swetter, K. Brooks, M.F. Demierre, and A.L. Yaroch Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions J Am Acad Dermatol 57 2007 555 572
26. E.L. Psaty, A. Scope, A.C. Halpern, and A.A. Marghoob Defining the patient at high risk for melanoma Int J Dermatol 49 2010 362 376
27. M.D. Corbo, R. Vender, and J. Wismer Comparison of dermatologists' and nondermatologists' diagnostic accuracy for malignant melanoma J Cutan Med Surg 16 2012 272 280
28. B.R. Cassileth, W.H. Clark Jr., E.J. Lusk, B.E. Frederick, C.J. Thompson, and W.P. Walsh How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol 14 1986 555 560
29. S.C. Chen, M.L. Pennie, P. Kolm, E.M. Warshaw, E.L. Weisberg, and K.M. Brown Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists J Gen Intern Med 21 2006 678 682
30. H.I. Meissner, C.N. Klabunde, P.K. Han, V.B. Bernard, and N. Breen Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United States Cancer 117 2011 3101 3111
31. R.J.T. van der Leest, E. de Vries, J.-L. Bulliard, J. Paoli, K. Peris, and A.J. Stratigos The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010 J Eur Acad Dermatol Venereol 25 2011 1455 1465
32. American Academy of Dermatology. Free skin cancer screenings. Available from: URL: http://www.aad.org/spot-skin-cancer/what-we-do/free-skin-cancer- screenings. Accessed July 25, 2012.
33. O.W. Brawley, and B.S. Kramer Cancer screening in theory and in practice J Clin Oncol 23 2005 293 300
34. D.B. Petitti, S.M. Teutsch, M.B. Barton, G.F. Sawaya, J.K. Ockene, and T. DeWitt US Preventive Services Task Force. Update on the methods of the US Preventive Services Task Force: insufficient evidence Ann Intern Med 150 2009 199 205
35. E. Losina, R.P. Walensky, A. Geller, F.C. Beddingfield III, L.L. Wolf, and B.A. Gilchrest Visual screening for melanoma: a cost-effectiveness analysis Arch Dermatol 143 2007 21 28
36. Y. Shen, and G. Parmigiani A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations Cancer Epidemiol Biomarkers Prev 14 2005 529 533
37. Kiewra K. What price health? Cost-effectiveness analysis can help society get the biggest bang for the buck. Harvard Public Health Review 2004. Available from: URL: http://www.hsph.harvard.edu/review/review-fall-04/risk-whatprice. html. Accessed March 29, 2011.
38. L.E. Johnson, A. Ousley, J. Swarz, R.J. Bingham, J.B. Erickson, S. Ellis, and T. Moody The art and science of cancer education and evaluation: toward facilitating improved patient outcomes J Cancer Educ 26 2011 27 35
39. Riter B. A brief history of breast cancer advocacy. Available from: URL: http://www.crcfl.net/content/view/history-of-breast-cancer-advocacy.html. Accessed February 20, 2012.
40. Susan G. Komen Foundation. Susan G. Komen for the Cure. Available from: URL: http://ww5.komen.org/. Accessed March 16, 2012.
41. J.A. Harvey The power of pink: cause-related marketing and the impact on breast cancer J Am Coll Radiol 6 2009 26 32
42. L.C. Wagner "It's for a good cause": the semiotics of the pink ribbon for breast cancer in print advertisements Intercultural Communication Studies 13 2005 209 216
43. M.M. Cordona, and J. Halliday Marketers think pink for breast cancer awareness Advertising Age 71 2000 18
44. C. Elliot Pink! Community, contestation, and the color of breast cancer Canadian Journal of Communication 32 2007 521 536
45. M. Haider Branding of international public health organizations: applying commercial marketing to global public health W.D. Evans, G. Hastings, Public health branding: applying marketing for social change 2008 Oxford University Press London 17 29
46. W.D. Evans, J. Blitstein, J.C. Hersey, J. Renaud, and A.L. Yaroch Systematic review of public health branding J Health Commun 13 2008 721 741
47. American Academy of Dermatology. Join SPOT Skin Cancer. Available from: URL: www.spotskincancer.org. Accessed March 18, 2012.
48. J.M. Kamell, W. Rietkerk, J. Phillips, C.H. Lam, J. McCullough, and K.G. Linden Medical students educate teens about skin cancer: what have we learned? J Cancer Educ 26 2011 153 155